Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Neuro-inflammatory effects of photodegradative products of bilirubin

J. Jašprová, M. Dal Ben, D. Hurný, S. Hwang, K. Žížalová, J. Kotek, RJ. Wong, DK. Stevenson, S. Gazzin, C. Tiribelli, L. Vítek,

. 2018 ; 8 (1) : 7444. [pub] 20180510

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19045460

Phototherapy was introduced in the early 1950's, and is the primary treatment of severe neonatal jaundice or Crigler-Najjar syndrome. Nevertheless, the potential biological effects of the products generated from the photodegradation of bilirubin during phototherapy remain unknown. This is very relevant in light of recent clinical observations demonstrating that the use of aggressive phototherapy can increase morbidity or even mortality, in extremely low birthweight (ELBW) infants. The aim of our study was to investigate the effects of bilirubin, lumirubin (LR, its major photo-oxidative product), and BOX A and B (its monopyrrolic oxidative products) on the central nervous system (CNS) using in vitro and ex vivo experimental models. The effects of bilirubin photoproducts on cell viability and expression of selected genes were tested in human fibroblasts, three human CNS cell lines (neuroblastoma SH-SY5Y, microglial HMC3, and glioblastoma U-87 cell lines), and organotypic rat hippocampal slices. Neither bilirubin nor its photo-oxidative products affected cell viability in any of our models. In contrast, LR in biologically-relevant concentrations (25 μM) significantly increased gene expression of several pro-inflammatory genes as well as production of TNF-α in organotypic rat hippocampal slices. These findings might underlie the adverse outcomes observed in ELBW infants undergoing aggressive phototherapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045460
003      
CZ-PrNML
005      
20200113082237.0
007      
ta
008      
200109s2018 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-018-25684-2 $2 doi
035    __
$a (PubMed)29748620
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Jašprová, J $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Neuro-inflammatory effects of photodegradative products of bilirubin / $c J. Jašprová, M. Dal Ben, D. Hurný, S. Hwang, K. Žížalová, J. Kotek, RJ. Wong, DK. Stevenson, S. Gazzin, C. Tiribelli, L. Vítek,
520    9_
$a Phototherapy was introduced in the early 1950's, and is the primary treatment of severe neonatal jaundice or Crigler-Najjar syndrome. Nevertheless, the potential biological effects of the products generated from the photodegradation of bilirubin during phototherapy remain unknown. This is very relevant in light of recent clinical observations demonstrating that the use of aggressive phototherapy can increase morbidity or even mortality, in extremely low birthweight (ELBW) infants. The aim of our study was to investigate the effects of bilirubin, lumirubin (LR, its major photo-oxidative product), and BOX A and B (its monopyrrolic oxidative products) on the central nervous system (CNS) using in vitro and ex vivo experimental models. The effects of bilirubin photoproducts on cell viability and expression of selected genes were tested in human fibroblasts, three human CNS cell lines (neuroblastoma SH-SY5Y, microglial HMC3, and glioblastoma U-87 cell lines), and organotypic rat hippocampal slices. Neither bilirubin nor its photo-oxidative products affected cell viability in any of our models. In contrast, LR in biologically-relevant concentrations (25 μM) significantly increased gene expression of several pro-inflammatory genes as well as production of TNF-α in organotypic rat hippocampal slices. These findings might underlie the adverse outcomes observed in ELBW infants undergoing aggressive phototherapy.
650    _2
$a zvířata $7 D000818
650    _2
$a bilirubin $x analogy a deriváty $x imunologie $7 D001663
650    _2
$a buněčné linie $7 D002460
650    _2
$a viabilita buněk $7 D002470
650    _2
$a hipokampus $x imunologie $x patologie $7 D006624
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a zánět $x imunologie $x patologie $7 D007249
650    _2
$a novorozenecká žloutenka $x terapie $7 D007567
650    _2
$a fotolýza $7 D010782
650    _2
$a fototerapie $x škodlivé účinky $7 D010789
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a TNF-alfa $x imunologie $7 D014409
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dal Ben, M $u Fondazione Italiana Fegato - ONLUS, AREA Science Park Basovizza, Trieste, Italy. Department of Medical, Surgical, and Health Sciences, University of Trieste, Trieste, Italy.
700    1_
$a Hurný, D $u Department of Inorganic Chemistry and Department of Organic Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Hwang, S $u Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA.
700    1_
$a Žížalová, K $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kotek, J $u Department of Inorganic Chemistry and Department of Organic Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Wong, R J $u Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
700    1_
$a Stevenson, D K $u Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
700    1_
$a Gazzin, S $u Fondazione Italiana Fegato - ONLUS, AREA Science Park Basovizza, Trieste, Italy.
700    1_
$a Tiribelli, C $u Fondazione Italiana Fegato - ONLUS, AREA Science Park Basovizza, Trieste, Italy.
700    1_
$a Vítek, L $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. vitek@cesnet.cz. 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. vitek@cesnet.cz.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 8, č. 1 (2018), s. 7444
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29748620 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113082608 $b ABA008
999    __
$a ok $b bmc $g 1483729 $s 1084133
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 8 $c 1 $d 7444 $e 20180510 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Archiving options